New scientific publications of the IDIAPJGol

Consult the latest articles in scientific journals on IDIAPJGol studies or with the participation of our researchers.

COVID-19 affects more the poorest areas of the city of Barcelona

This is certified by a joint study by the Hospital del Mar Institute for Medical Research and IDIAPJGol, which reveals that the districts of the city of Barcelona with a lower average income were the most affected by the first wave of the pandemic.

Open call for research aids in Primary Health Care 2020

The call for aid from IDIAPJGol, in collaboration with ICS, is now open. You can consult the bases and information of all the calls in our website.  

FONDO SUPERA COVID-19 selects a study led by the Hospital de Mar Medical Research Institute, the Hospital del Mar and the University of Girona/IDIBGI, also involving the University of Vic and IDIAPJGol

The project is one of 12 selected by the evaluation committee and will receive the second highest amount of money, 250,000 euros. The study, which involves the University of Girona, the University of Vic-Central-University of Catalonia and the Foundation for Higher Studies in Health Sciences, the Trueta and Santa Caterina hospitals and the University Institute for Primary Health Care Research (IDIAP-Jordi Gol), with the company Gen inCode and several healthcare centres in the United States also showing an interest, will analyse genetic predisposition to coronary risk as a prognostic element of severity in the event of contracting COVID-19.

El curs d'introducció a "R" serà en format online

L'objectiu de la formació, que s'impartirà a l'octubre i novembre a la plataforma Moodle, és que l'estudiant obtingui els coneixements d'estadística aplicada per al tractament i anàlisi de dades mitjançant el programa estadístic R. 

Recruitment of professionals has begun for a clinical trial that will verify the protective effect of a food supplement against SARS-CoV-2

On July 14, the recruitment of professionals from health centers began in the North and South Metropolitan Area to evaluate the efficacy of the Manremyc® food supplement to prevent SARS-CoV-2 infection in personnel with high exposure to the virus.